<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2017-21-1-57-67</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-224</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ. ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES. EXPERIMENTAL INVESTIGATION</subject></subj-group></article-categories><title-group><article-title>ВЛИЯНИЕ КОМБИНИРОВАННОГО ВВЕДЕНИЯ КРЫСАМ ТИРОКСИНА И ПРОПИЛТИОУРАЦИЛА НА СТРУКТУРНЫЕ ПОКАЗАТЕЛИ ПОЧЕЧНОЙ ПАРЕНХИМЫ</article-title><trans-title-group xml:lang="en"><trans-title>INFLUENCE OF COMBINED INJECTION OF THYROXIN AND PROPYLTHIOURACILUM ON SCTRUCTURAL INDICATORS OF RENAL PARENCHYMA</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Доломатов</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Dolomatov</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доцент Доломатов Сергей Игоревич, кандидат биологических наук</p><p>Кафедра биологии медицинской</p><p>295006, Россия, г. Симферополь, бул. Ленина, д. 5/7</p></bio><bio xml:lang="en"><p>Associate prof Sergey I. Dolomatov MD, PhD. </p><p>295006, Russia, Simferopol, Lenin boulevard, 5/7. </p></bio><email xlink:type="simple">path888d@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сиповский</surname><given-names>В. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Sipovski</surname><given-names>V. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доцент Сиповский Василий Георгиевич, кандидат медицинских наук </p><p>Научно-исследовательский институт нефрологии </p><p>197089, Россия, Санкт-Петербург, ул. Льва Толстого, д. 17</p></bio><bio xml:lang="en"><p>Associate prof. Vassili G. Sipovski MD, PhD. </p><p>Research Institute of Nephrology </p><p>197022, Russia, Saint-Petersburg, Str. Leo Tolstoy, 17</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новиков</surname><given-names>Н. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Novikov</surname><given-names>N. Y.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новиков Николай Юлиевич, доктор медицинских наук, старший научный сотрудник.</p></bio><bio xml:lang="en"><p>Senior Researcher Nikolay J. Novikov MD, PhD, DMedSci.</p><p>249031, Russia, Obninsk, Marshal Zhukov str. 10. </p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Касич</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kasich</surname><given-names>I. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Касич Игорь Николаевич - студент</p></bio><bio xml:lang="en"><p>Student Igor N. Kasich</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мышко</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Myshko</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мышко Илья Владимирович - студент</p></bio><bio xml:lang="en"><p>Student Ilya V. Myshko</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дери</surname><given-names>К.</given-names></name><name name-style="western" xml:lang="en"><surname>Deri</surname><given-names>К.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дери Карим - студент</p></bio><bio xml:lang="en"><p>Student Karim Deri</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Литвиненко</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Lytvinenko</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Литвиненко Антон Николаевич </p><p>350911, Россия, г. Краснодар, ул. Садовая, д. 9. </p></bio><bio xml:lang="en"><p>Anton N. Lytvinenko MD. </p><p>350911, Russia, Krasnodar, Sadovaya str. 9. </p></bio><xref ref-type="aff" rid="aff-5"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Медицинская академия им. С.И. Георгиевского, Крымского Федерального университета им. В.И. Вернадского</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical Academy named after S.I. Georgievsky of V.I. Vernadsky Crimean Federal University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>First Pavlov Saint Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Медицинский радиологический научный центр им. А.Ф. Цыба, филиал Национального медицинского исследовательского радиологического центра</institution><country>Россия</country></aff><aff xml:lang="en"><institution>A. Tsyba Medical Radiological Research Centre – branch of the National Medical Research Radiological Centre</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Медицинская академия им. С.И. Георгиевского Крымского Федерального университета им. В.И. Вернадского.</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical Academy named after S.I. Georgievsky of V.I. Vernadsky Crimean Federal University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>Городская поликлиника №11.</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Polyclinic №11</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>03</day><month>03</month><year>2017</year></pub-date><volume>21</volume><issue>1</issue><fpage>57</fpage><lpage>67</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Доломатов С.И., Сиповский В.Г., Новиков Н.Ю., Касич И.Н., Мышко И.В., Дери К., Литвиненко А.Н., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Доломатов С.И., Сиповский В.Г., Новиков Н.Ю., Касич И.Н., Мышко И.В., Дери К., Литвиненко А.Н.</copyright-holder><copyright-holder xml:lang="en">Dolomatov S.I., Sipovski V.G., Novikov N.Y., Kasich I.N., Myshko I.V., Deri К., Lytvinenko A.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/224">https://journal.nephrolog.ru/jour/article/view/224</self-uri><abstract><p>ЦЕЛЬ РАБОТЫ – изучение динамики структурных изменений ренальной паренхимы крыс, подвергавшихся длительному комбинированному воздействию тироксина и ПТУ. МАТЕРИАЛЫ И МЕТОДЫ. Исследования проведены на беспородных самцах белых крыс массой тела 250–300 г. Гипертиреоз вызывали ежедневным внутрижелудочным введением тироксина (Т4) в количестве 50 мкг на100 гмассы тела на протяжении 30 сут. В первый день эксперимента животные были разделены на 2 группы. Животные первой группы (n=25) получали только Т4. Крысам второй группы (n=25) ежедневно вводили Т4+пропилтиоурацил (ПТУ). ПТУ вводили внутрижелудочно по 1 мг на100 гмассы тела. Пробы тканей почек собирали на 10-, 20-е и 30-е сутки эксперимента. Кроме того, был проведен сбор образцов ткани почек животных, получавших только Т4 через 20 сут после прекращения введения гормона. Полученные пробы ткани фиксировали и обрабатывали по общепринятой методике с последующей заливкой в парафин. Срезы окрашивали гематоксилином и эозином. РЕЗУЛЬТАТЫ. Установлено, что течение экспериментального гипертиреоза приводит к существенным структурным нарушениям почечной паренхимы. Ведущие проявления патологии почек при гипертиреозе – это грубые структурные повреждения канальцевого эпителия нефрона. ЗАКЛЮЧЕНИЕ. Комбинированное введение крысам тироксина и пропилтиоурацила дает слабо выраженный благоприятный эффект, ограничивая развитие структурных повреждений ренальной паренхимы и образования тромбов. </p></abstract><trans-abstract xml:lang="en"><p>THE AIM: to study of the dynamics of structural changes in renal parenchyma of rats exposed to long-term combined effects of thyroxine and propylthiouracilum (PTU). MATHERIAL AND METHODS – studies were performed on mongrel white male rats weighing 250-300g. Hyperthyroidism was caused by daily intragastric administration of thyroxine (T4) in amount of 50g per 100g of body weight over 30 days. On the first day of the experiment animals were divided into 2 groups. Animals of the first group (n = 25) received only T4. The rats of the second group (n = 25) were administrated propylthiouracilum and T4 daily. PTU was administered intragastric in amount of 1 mg per 100g of body weight. Kidney tissue samples were collected on the 10th, 20th and 30th days of the experiment. In addition, there were collected kidney tissue samples of the animals treated with only T4 after 20 days after cessation of hormone. Obtained tissue samples were fixed and treated by the usual method, followed by filling in paraffin. Sections were stained with hematoxylin and eosin. RESULTS – it was established that course of experimental hyperthyroidism leads to significant structural abnormalities of the renal parenchyma. Leading features of kidneys pathology at a hyperthyroidism are rough structural damages of the nephron tubular epithelium. CONCLUSIONS – combined administration in rats of thyroxin and propylthiouracilum has weakly expressed beneficial effect by limiting the development of structural damages to the renal parenchyma and clot formation. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>крысы</kwd><kwd>почка</kwd><kwd>гипертиреоз</kwd><kwd>пропилтиоурацил</kwd></kwd-group><kwd-group xml:lang="en"><kwd>rats</kwd><kwd>kidney</kwd><kwd>hyperthyroidism</kwd><kwd>propylthiouracilum</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Basu G, Mohapatra A. Interactions between thyroid disorders and kidney disease. Indian J Endocr Metab 2012;16(2):204213. DOI: 10.4103/2230-8210.93737</mixed-citation><mixed-citation xml:lang="en">Basu G, Mohapatra A. Interactions between thyroid disorders and kidney disease. Indian J Endocr Metab 2012;16(2):204213. DOI: 10.4103/2230-8210.93737</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kim EO, Lee IS, Choi YA et al. Unresolved Subclinical Hypothyroidism is Independently Associated with Progression of Chronic Kidney Disease. Int J Med Sci 2014; 11(1): 52–59. doi: 10.7150/ijms.7186</mixed-citation><mixed-citation xml:lang="en">Kim EO, Lee IS, Choi YA et al. Unresolved Subclinical Hypothyroidism is Independently Associated with Progression of Chronic Kidney Disease. Int J Med Sci 2014; 11(1): 52–59. doi: 10.7150/ijms.7186</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Dousdampanis P, Trigka K, Vagenakis GA, Fourtounas C. The thyroid and the kidney: a complex interplay in health and disease. Int J Artif Organs 2014;37(1):1-12. doi: 10.5301/ijao.5000300</mixed-citation><mixed-citation xml:lang="en">Dousdampanis P, Trigka K, Vagenakis GA, Fourtounas C. The thyroid and the kidney: a complex interplay in health and disease. Int J Artif Organs 2014;37(1):1-12. doi: 10.5301/ijao.5000300</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Iglesias P, Díez J. Thyroid dysfunction and kidney disease. European Journal of Endocrinology 2009;160:503-515</mixed-citation><mixed-citation xml:lang="en">Iglesias P, Díez J. Thyroid dysfunction and kidney disease. European Journal of Endocrinology 2009;160:503-515</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Vargas F, Rodríguez-Gómez I, Vargas-Tendero P et al. The renin–angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations. Journal of Endocrinology 2012;213:25-36</mixed-citation><mixed-citation xml:lang="en">Vargas F, Rodríguez-Gómez I, Vargas-Tendero P et al. The renin–angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations. Journal of Endocrinology 2012;213:25-36</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y, Chang Y, Ryu S et al. Thyroid hormone levels and incident chronic kidney disease in euthyroid individuals: the Kangbuk Samsung Health Study. Int J Epidemiol 2014;43(5):1624-1632. doi: 10.1093/ije/dyu126</mixed-citation><mixed-citation xml:lang="en">Zhang Y, Chang Y, Ryu S et al. Thyroid hormone levels and incident chronic kidney disease in euthyroid individuals: the Kangbuk Samsung Health Study. Int J Epidemiol 2014;43(5):1624-1632. doi: 10.1093/ije/dyu126</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wangensteen R, Segarra AB, Ramirez-Sanchez M et al. Influence of thyroid disorders on the kidney expression and plasma activity of aminopeptidase A. Endocr Regul. 2015;49(2):68-72</mixed-citation><mixed-citation xml:lang="en">Wangensteen R, Segarra AB, Ramirez-Sanchez M et al. Influence of thyroid disorders on the kidney expression and plasma activity of aminopeptidase A. Endocr Regul. 2015;49(2):68-72</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dolomatov S, Muszkieta R, Zukow W Experimental Investigation of Acute and Delayed Renal Effect of Exogenous Thyroxine. Thyroid Disorders &amp; Therapy 2012; 1:1. doi.org/10.4172/jtdt.1000105</mixed-citation><mixed-citation xml:lang="en">Dolomatov S, Muszkieta R, Zukow W Experimental Investigation of Acute and Delayed Renal Effect of Exogenous Thyroxine. Thyroid Disorders &amp; Therapy 2012; 1:1. doi.org/10.4172/jtdt.1000105</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Dolomatov S, Novikov N, Zukow W et al. Effect of captopril and losartan on the structural and functional indicators kidneys of white rats in experimental hyperthyroidism. J of Health Sciences 2011;1(3):147-166</mixed-citation><mixed-citation xml:lang="en">Dolomatov S, Novikov N, Zukow W et al. Effect of captopril and losartan on the structural and functional indicators kidneys of white rats in experimental hyperthyroidism. J of Health Sciences 2011;1(3):147-166</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tofangchiha S, Jamshidi SM, Emami H, Dormanesh B. Investigating Antithyroid Effects of Propylthiouracil on the Ischemia and Reperfusion Injury in Rat’ Kidney and Determining the Role of Nitric Oxide in Mediating this Effect. Iran Red Crescent Med J 2014;16(10):e15605. doi: 10.5812/ircmj.15605</mixed-citation><mixed-citation xml:lang="en">Tofangchiha S, Jamshidi SM, Emami H, Dormanesh B. Investigating Antithyroid Effects of Propylthiouracil on the Ischemia and Reperfusion Injury in Rat’ Kidney and Determining the Role of Nitric Oxide in Mediating this Effect. Iran Red Crescent Med J 2014;16(10):e15605. doi: 10.5812/ircmj.15605</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">El Ters M, Patel SM, Norby SM. Hypothyroidism and reversible kidney dysfunction: an essential relationship to recognize. Endocr Pract 2014;20(5):490-499. doi: 10.4158/EP12084.RA</mixed-citation><mixed-citation xml:lang="en">El Ters M, Patel SM, Norby SM. Hypothyroidism and reversible kidney dysfunction: an essential relationship to recognize. Endocr Pract 2014;20(5):490-499. doi: 10.4158/EP12084.RA</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Rodríguez-Gómez I, Banegas I, Wangensteen R et al. Influence of thyroid state on cardiac and renal capillary density and glomerular morphology in rats. J Endocrinol 2013;216:43-51. doi: 10.1530/JOE-12-0208</mixed-citation><mixed-citation xml:lang="en">Rodríguez-Gómez I, Banegas I, Wangensteen R et al. Influence of thyroid state on cardiac and renal capillary density and glomerular morphology in rats. J Endocrinol 2013;216:43-51. doi: 10.1530/JOE-12-0208</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lavado-Autric R, Calvo RM, de Mena RM et al. Deiodinase activities in thyroids and tissues of iodine-deficient female rats. Endocrinology 2013;154(1):529-536. doi: 10.1210/en.2012-1727</mixed-citation><mixed-citation xml:lang="en">Lavado-Autric R, Calvo RM, de Mena RM et al. Deiodinase activities in thyroids and tissues of iodine-deficient female rats. Endocrinology 2013;154(1):529-536. doi: 10.1210/en.2012-1727</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Niemczyk S, Dudek M, Bartoszewicz Z et al. Determining the enzymatic activities of iodothyronine 5’-deiodinases in renal medulla and cortex. Endokrynol Pol 2013;64(3):182-185</mixed-citation><mixed-citation xml:lang="en">Niemczyk S, Dudek M, Bartoszewicz Z et al. Determining the enzymatic activities of iodothyronine 5’-deiodinases in renal medulla and cortex. Endokrynol Pol 2013;64(3):182-185</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ichihara A, Kobori H, Miyashita Y et al. Differential effects of thyroid hormone on renin secretion, content, and mRNA in juxtaglomerular cells. Am J Physiol Endocrinol Metab 1998;274(2):E224-231 16. Kobori H, Hayashi M, Saruta T. Thyroid Hormone Stimulates Renin Gene Expression Through the Thyroid Hormone Response Element. Hypertension 2001;37(1):99-104</mixed-citation><mixed-citation xml:lang="en">Ichihara A, Kobori H, Miyashita Y et al. Differential effects of thyroid hormone on renin secretion, content, and mRNA in juxtaglomerular cells. Am J Physiol Endocrinol Metab 1998;274(2):E224-231 16. Kobori H, Hayashi M, Saruta T. Thyroid Hormone Stimulates Renin Gene Expression Through the Thyroid Hormone Response Element. Hypertension 2001;37(1):99-104</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Доломатов СИ, Гоженко АИ, Ларина ИМ и др. Влияние натриевого рациона и каптоприла на функциональное состояние почек при экспериментальном гипертиреозе. Экспер и клин фармакол 2005;68(5):26–28 [Dolomatov SI, Gozhenko AI, Larina IM i dr. Vliyanie natrievogo raciona i kaptoprila na funkcional’noe sostoyanie pochek pri ehksperimental’nom gipertireoze. Eksperimental’naya i klinicheskaya farmakologiya 2005;68(5):26–28]</mixed-citation><mixed-citation xml:lang="en">Доломатов СИ, Гоженко АИ, Ларина ИМ и др. Влияние натриевого рациона и каптоприла на функциональное состояние почек при экспериментальном гипертиреозе. Экспер и клин фармакол 2005;68(5):26–28 [Dolomatov SI, Gozhenko AI, Larina IM i dr. Vliyanie natrievogo raciona i kaptoprila na funkcional’noe sostoyanie pochek pri ehksperimental’nom gipertireoze. Eksperimental’naya i klinicheskaya farmakologiya 2005;68(5):26–28]</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Dolomatov SI, Sataieva TP. Effect of ras-blockers and nocycle metabolites on the renal functions of rats exposed to thyroxine injections. J of Education, Health and Sport 2015;5(1):41-55</mixed-citation><mixed-citation xml:lang="en">Dolomatov SI, Sataieva TP. Effect of ras-blockers and nocycle metabolites on the renal functions of rats exposed to thyroxine injections. J of Education, Health and Sport 2015;5(1):41-55</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kobori H, Nangaku M, Navar LG, Nishiyama A. The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease. Pharmacol Rev 2007;59:251-287</mixed-citation><mixed-citation xml:lang="en">Kobori H, Nangaku M, Navar LG, Nishiyama A. The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease. Pharmacol Rev 2007;59:251-287</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Li XC, Zhuo JL. Intracellular ANG II directly induces in vitro transcription of TGF-β1, MCP-1, and NHE-3 mRNAs in isolated rat renal cortical nuclei via activation of nuclear AT1a receptors. Am J Physiol Cell Physiol 2008;294:C1034-C1045</mixed-citation><mixed-citation xml:lang="en">Li XC, Zhuo JL. Intracellular ANG II directly induces in vitro transcription of TGF-β1, MCP-1, and NHE-3 mRNAs in isolated rat renal cortical nuclei via activation of nuclear AT1a receptors. Am J Physiol Cell Physiol 2008;294:C1034-C1045</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Li J, Doerffel Y, Hocher B, Unger Th Inflammation in the genesis of hypertension and its complications—the role of angiotensin II. Nephrology Dialysis Transplantation 2007;22(11):3107-3109</mixed-citation><mixed-citation xml:lang="en">Li J, Doerffel Y, Hocher B, Unger Th Inflammation in the genesis of hypertension and its complications—the role of angiotensin II. Nephrology Dialysis Transplantation 2007;22(11):3107-3109</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Ruiz-Ortega M, Rodríguez-Vita J, Sanchez-Lopez E et al. TGF-β signaling in vascular fibrosis. Cardiovascular Research 2007;74(2):196-206</mixed-citation><mixed-citation xml:lang="en">Ruiz-Ortega M, Rodríguez-Vita J, Sanchez-Lopez E et al. TGF-β signaling in vascular fibrosis. Cardiovascular Research 2007;74(2):196-206</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Bhaskaran M, Reddy K, Radhakrishanan N et al. Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 2003;284(5):F955-F965</mixed-citation><mixed-citation xml:lang="en">Bhaskaran M, Reddy K, Radhakrishanan N et al. Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 2003;284(5):F955-F965</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Seg n a D, Méan M, Limacher A et al. Association between thyroid dysfunction and venous thromboembolism in the elderly: a prospective cohort study. J Thromb Haemost 2016;14(4):685-694</mixed-citation><mixed-citation xml:lang="en">Seg n a D, Méan M, Limacher A et al. Association between thyroid dysfunction and venous thromboembolism in the elderly: a prospective cohort study. J Thromb Haemost 2016;14(4):685-694</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Lippi G, Danese E, Montagnana M et al. Mean platelet volume is significantly associated with serum levels of thyroidstimulating hormone in a cohort of older euthyroid subjects. Endocr Res 2015;40(4):227-230 doi:10.3109/07435800.2015.1037392</mixed-citation><mixed-citation xml:lang="en">Lippi G, Danese E, Montagnana M et al. Mean platelet volume is significantly associated with serum levels of thyroidstimulating hormone in a cohort of older euthyroid subjects. Endocr Res 2015;40(4):227-230 doi:10.3109/07435800.2015.1037392</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Wojewodzka-Zelezniakowicz M, Kisiel W, Kramkowski K et al. Quinapril decreases antifibrinolytic and prooxidative potential of propofol in arterial thrombosis in hypertensive rats. J Renin Angiotensin Aldosterone Syst 2016;17(2). pii: 1470320316647239. doi: 10.1177/1470320316647239</mixed-citation><mixed-citation xml:lang="en">Wojewodzka-Zelezniakowicz M, Kisiel W, Kramkowski K et al. Quinapril decreases antifibrinolytic and prooxidative potential of propofol in arterial thrombosis in hypertensive rats. J Renin Angiotensin Aldosterone Syst 2016;17(2). pii: 1470320316647239. doi: 10.1177/1470320316647239</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Gereben B, Zavack i AM, Ribich S et al. Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling. Endocrin e Reviews 2008; 29(7):898-938. doi:10.1210/er.2008-0019</mixed-citation><mixed-citation xml:lang="en">Gereben B, Zavack i AM, Ribich S et al. Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling. Endocrin e Reviews 2008; 29(7):898-938. doi:10.1210/er.2008-0019</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Nigwekar SU, Strippoli GF, Navaneethan SD. Thyroid hormones for acute kidney injury. Cochrane Database Syst Rev 2013 31;1:CD006740. doi: 10.1002/14651858.CD006740.pub2</mixed-citation><mixed-citation xml:lang="en">Nigwekar SU, Strippoli GF, Navaneethan SD. Thyroid hormones for acute kidney injury. Cochrane Database Syst Rev 2013 31;1:CD006740. doi: 10.1002/14651858.CD006740.pub2</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Shang G, Gao P, Zhao Z et al. 3,5-Diiodo-l-thyronine ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats. Biochim Biophys Acta. 2013;1832(5):674-684. doi: 10.1016/j.bbadis.2013.01.023</mixed-citation><mixed-citation xml:lang="en">Shang G, Gao P, Zhao Z et al. 3,5-Diiodo-l-thyronine ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats. Biochim Biophys Acta. 2013;1832(5):674-684. doi: 10.1016/j.bbadis.2013.01.023</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Faustino LC, Almeida NAS, Pereira GF et al. Thyroid hormone and estradiol have overlapping effects on kidney glutathione S-transferase-α gene expression. Am J of Physiol – Endocrinol and Metabolism 2012;303(6): E787-E797. DOI: 10.1152/ajpendo.00223.2012</mixed-citation><mixed-citation xml:lang="en">Faustino LC, Almeida NAS, Pereira GF et al. Thyroid hormone and estradiol have overlapping effects on kidney glutathione S-transferase-α gene expression. Am J of Physiol – Endocrinol and Metabolism 2012;303(6): E787-E797. DOI: 10.1152/ajpendo.00223.2012</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Kim SM, Kim SW, Jung YJ et al. Preconditioning with thyroid hormone (3,5,3-triiodothyronine) prevents renal ischemiareperfusion injury in mice. Surgery 2014;155(3):554-561. doi: 10.1016/j.surg.2013.10.005</mixed-citation><mixed-citation xml:lang="en">Kim SM, Kim SW, Jung YJ et al. Preconditioning with thyroid hormone (3,5,3-triiodothyronine) prevents renal ischemiareperfusion injury in mice. Surgery 2014;155(3):554-561. doi: 10.1016/j.surg.2013.10.005</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">St. Germain DL, Galton VA, Hernandez A. Defining the Roles of the Iodothyronine Deiodinases: Current Concepts and Challenges. Endocrinology 2009;150(3):1097-1107</mixed-citation><mixed-citation xml:lang="en">St. Germain DL, Galton VA, Hernandez A. Defining the Roles of the Iodothyronine Deiodinases: Current Concepts and Challenges. Endocrinology 2009;150(3):1097-1107</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Sepehri G, Derakhshanfar A, Saburi L. Does Propylthiouracil Increase the Gentamicin-Induced Nephrotoxicity In Rat? Iran J Basic Med Sci 2013;16(11): 1190–1195</mixed-citation><mixed-citation xml:lang="en">Sepehri G, Derakhshanfar A, Saburi L. Does Propylthiouracil Increase the Gentamicin-Induced Nephrotoxicity In Rat? Iran J Basic Med Sci 2013;16(11): 1190–1195</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
